CDK 4/6 Inhibitors in Metastatic Breast Cancer

1 Pogledi
administrator
administrator
07/03/23

Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći